Literature DB >> 15361191

Do the pelvic lymph nodes predict the parametrial status in cervical cancer stages IB-IIA?

R Puente1, S Guzman, E Israel, M T Poblete.   

Abstract

The aim of this study was to determine whether the pelvic lymph nodes would predict the parametrial status in patients with cervical cancer stages IB1-IIA submitted to radical surgery and pelvic lymphadenectomy. To this end, we evaluated the relationship between positive and negative pelvic lymph nodes and their parametria. Our final purpose was to use this information to recommend the tailoring of the parametrial resection according to the status of pelvic lymph nodes to decrease the morbidity related with radical paratrectomy. From January 1996 to December 2001, 107 consecutive patients with cervical cancer stages IB1 and IIA were primarily treated by radical hysterectomy type III with systematic pelvic lymphadenectomy in a prospective study. Parametria were studied in two sections: the first included the tissue adjacent to the cervix, and the second the distal 2/3. Lymph nodes were routinary processed. Twenty-two patients (20.6%) had positive pelvic nodes and 16 patients (14.9%) had parametrial involvement, mostly by direct extension. Eight patients with positive pelvic nodes (36.4%) had parametrial involvement, whereas among 85 patients with negative pelvic nodes only eight patients (9.4%) had parametrial involvement (P < 0.001), most in internal parametria (62.5%). The sensitivity of pelvic lymph nodes for parametrial involvement was 50% and the positive predictive value was 36.4%, whereas the specificity was 84.6%; and the negative predictive value 90.6%. In the group of negative pelvic lymph nodes, only two patients (2.3%) had parametrial involvement beyond internal parametria. The univariated and multivariated analysis of prognostic factors was always significant but without a significant independent factor for positive parametria. Pelvic lymph nodes appear as good predictors of parametrial status, especially in node-negative patients, and could be used to decrease the paratrectomy in radical surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15361191     DOI: 10.1111/j.1048-891X.2004.14517.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.

Authors:  John P Diaz; Mary L Gemignani; Neeta Pandit-Taskar; Kay J Park; Melissa P Murray; Dennis S Chi; Yukio Sonoda; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2011-01-08       Impact factor: 5.482

2.  Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.

Authors:  Hiroyuki Yamazaki; Yukiharu Todo; Kazuhira Okamoto; Katsushige Yamashiro; Hidenori Kato
Journal:  J Gynecol Oncol       Date:  2015-07-14       Impact factor: 4.401

Review 3.  Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.

Authors:  Emily S Wu; Jose Jeronimo; Sarah Feldman
Journal:  J Glob Oncol       Date:  2017-05-11

4.  The Relationship Between Parametrial Involvement and Parametrial Tissue Removed in Radical Surgery in Early-Stage Cervical Cancer.

Authors:  Ozer Birge; Mehmet Sait Bakir; Selen Dogan; Hasan Aykut Tuncer; Tayup Simsek
Journal:  World J Oncol       Date:  2022-04-23

5.  Factors associated with parametrial involvement in patients with stage IB1 cervical cancer: Who is suitable for less radical surgery?

Authors:  Seung-Ho Lee; Kyoung-Joo Cho; Mi-Hyang Ko; Hyun-Yee Cho; Kwang-Beom Lee; Soyi Lim
Journal:  Obstet Gynecol Sci       Date:  2017-12-15

6.  Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.

Authors:  Heng-Cheng Hsu; Yi-Jou Tai; Yu-Li Chen; Ying-Cheng Chiang; Chi-An Chen; Wen-Fang Cheng
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.